Experienced in Primary Immunodeficiency (PID)

Dr. Lynne S. Kaminer

Hematology
Endeavor Health Medical Group
2650 Ridge Ave, 
Evanston, IL 
Accepting New Patients
Offers Telehealth
43 Years of Experience
Experienced in Primary Immunodeficiency (PID)
Endeavor Health Medical Group
2650 Ridge Ave, 
Evanston, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Lynne Kaminer is a Hematologist in Evanston, Illinois. Dr. Kaminer has been practicing medicine for over 43 years and is rated as an Experienced provider by MediFind in the treatment of Primary Immunodeficiency (PID). Her top areas of expertise are Non-Hodgkin Lymphoma, Small Lymphocytic Lymphoma (SLL), Chronic Lymphocytic Leukemia (CLL), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Kaminer is currently accepting new patients.

Her clinical research consists of co-authoring 5 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Year
1982
Specialties
Hematology
Licenses
Internal Medicine in IL
Hospital Affiliations
Swedish Hospital
Northshore University Healthsystem - Evanston Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
HMSA
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Zing Health
  • MEDICARE MAPD
  • MEDICARE SNP
View 13 Less Insurance Carriers -

Locations

ENDEAVOR HEALTH MEDICAL GROUP
2650 Ridge Ave, Evanston, IL 60201
Other Locations
ENDEAVOR HEALTH MEDICAL GROUP
2739 W Foster Ave, Chicago, IL 60625
ENDEAVOR HEALTH MEDICAL GROUP
777 Park W Ave, Highland Park, IL 60035

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase II/III Randomized Study of R-MiniCHOP With or Without CC-486 (Oral Azacitidine) in Participants Age 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma, Grade IIIB Follicular Lymphoma, Transformed Lymphoma, and High-Grade B-Cell Lymphomas With MYC AND BCL2 and/or BCL6 Rearrangements
A Phase II/III Randomized Study of R-MiniCHOP With or Without CC-486 (Oral Azacitidine) in Participants Age 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma, Grade IIIB Follicular Lymphoma, Transformed Lymphoma, and High-Grade B-Cell Lymphomas With MYC AND BCL2 and/or BCL6 Rearrangements
Enrollment Status: Suspended
Publish Date: October 06, 2025
Intervention Type: Drug, Biological, Procedure, Other
Study Drugs: Cyclophosphamide, Doxorubicin Hydrochloride, Oral Azacitidine, Prednisone, Rituximab, Vincristine Sulfate
Study Phase: Phase 2/Phase 3
A Phase III Randomized Trial of Blinatumomab for Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia in Adults
A Phase III Randomized Trial of Blinatumomab for Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia in Adults
Enrollment Status: Active_not_recruiting
Publish Date: September 26, 2025
Intervention Type: Drug, Procedure, Biological
Study Drugs: Blinatumomab, Cyclophosphamide, Cytarabine, Daunorubicin, Daunorubicin Hydrochloride, Dexamethasone, Etoposide, Mercaptopurine, Methotrexate, Pegaspargase, Prednisone, Rituximab, Vincristine, Vincristine Sulfate
Study Phase: Phase 3
A Phase III Trial to Evaluate the Efficacy of the Addition of Inotuzumab Ozogamicin (a Conjugated Anti-CD22 Monoclonal Antibody) to Frontline Therapy in Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL
A Phase III Trial to Evaluate the Efficacy of the Addition of Inotuzumab Ozogamicin (a Conjugated Anti-CD22 Monoclonal Antibody) to Frontline Therapy in Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL
Enrollment Status: Suspended
Publish Date: September 05, 2025
Intervention Type: Biological, Drug, Procedure, Other
Study Drugs: Allopurinol, Cytarabine, Daunorubicin Hydrochloride, Vincristine Sulfate, Dexamethasone, Pegylated L-Asparaginase, Methotrexate, Cyclophosphamide, Mercaptopurine, Rituximab, Doxorubicin, Thioguanine, Inotuzumab
Study Phase: Phase 3
View 2 Less Clinical Trials

5 Total Publications

A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL.
A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL.
Journal: Blood advances
Published: May 13, 2025
Similar Doctors
Robert A. Bayer
Advanced in Primary Immunodeficiency (PID)
Dr. Robert A. Bayer
Hematology | Oncology
Advanced in Primary Immunodeficiency (PID)
Dr. Robert A. Bayer
Hematology | Oncology
10 Health Service Dr, 
Dekalb, IL 
 (53.7 miles away)
815-756-5255
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Robert Bayer is a Hematologist and an Oncologist in Dekalb, Illinois. Dr. Bayer is rated as a Distinguished provider by MediFind in the treatment of Primary Immunodeficiency (PID). His top areas of expertise are Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Lynch Syndrome, and Colorectal Cancer.

Jayesh Mehta
Experienced in Primary Immunodeficiency (PID)
Dr. Jayesh Mehta
Hematology
Experienced in Primary Immunodeficiency (PID)
Dr. Jayesh Mehta
Hematology
675 N St Clair St Ste 21-100, Galter Pavilion, 
Chicago, IL 
 (12.3 miles away)
866-587-4322
Experience:
39+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jayesh Mehta is a Hematologist in Chicago, Illinois. Dr. Mehta has been practicing medicine for over 39 years and is rated as a Distinguished provider by MediFind in the treatment of Primary Immunodeficiency (PID). His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Bone Marrow Aspiration.

Malik T. Bandealy
Experienced in Primary Immunodeficiency (PID)
Dr. Malik T. Bandealy
Hematology | Oncology
Experienced in Primary Immunodeficiency (PID)
Dr. Malik T. Bandealy
Hematology | Oncology

Vince Lombardi Cancer Clinic

6811 118th Ave, 
Kenosha, WI 
 (37.7 miles away)
262-857-5750
Languages Spoken:
English, Hindi, Urdu
See accepted insurances
Offers Telehealth

Malik Bandealy is a Hematologist and an Oncologist in Kenosha, Wisconsin. Dr. Bandealy is rated as a Distinguished provider by MediFind in the treatment of Primary Immunodeficiency (PID). His top areas of expertise are Angiosarcoma, Paget Disease of the Breast, Thrombocytopenia, and Adult Immune Thrombocytopenia.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kaminer's expertise for a condition
ConditionClose
    View All 17 Distinguished Conditions
    View All 37 Advanced Conditions
    View All 54 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile